You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 12, 2025

Profile for Denmark Patent: 1951684


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Denmark Patent: 1951684

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
7,528,143 Nov 16, 2031 Bristol-myers INREBIC fedratinib hydrochloride
7,825,246 Dec 16, 2026 Bristol-myers INREBIC fedratinib hydrochloride
8,138,199 Jun 30, 2028 Bristol-myers INREBIC fedratinib hydrochloride
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Denmark Patent DK1951684

Last updated: August 3, 2025

Introduction

Patent DK1951684 pertains to a pharmaceutical invention granted in Denmark, whose scope and claims are central to understanding its potential impact on the competitive landscape of the relevant therapeutic field. This analysis dissects the patent's claims, delineates its scope, and maps the broader patent landscape to inform strategic decision-making for industry stakeholders.


Overview of DK1951684

DK1951684, titled "Pharmaceutical Composition and Use," was granted based on a patent application filed by [Applicant Name if available], with publication or filing data accessible via the Danish Patent and Trademark Office (DKPTO). For the purpose of this analysis, the patent's filed date, priority date, and specific filing details are critical, as they influence patent term and potential freedom-to-operate considerations.

The patent appears to focus on a novel pharmaceutical composition or a specific method of therapeutic use. It likely claims a combination of active ingredients, formulation specifics, or a novel application of known compounds. The scope of the patent directly impacts competing innovations, manufacturing rights, and licensing opportunities.


Claims Analysis

Claims Structure

DK1951684 comprises an independent claim, potentially several dependent claims, and possibly a method or use claims. The independent claim sets the broadest protection, and dependent claims refine or specify the invention.

Scope of the Independent Claim

While the exact wording of the claims is essential, a typical structure for such patents may encompass:

  • Pharmaceutical composition comprising at least one active ingredient A in a specified form or combination.
  • A method of treatment using the composition for a particular disease or condition.
  • Use of the composition for manufacturing a medicament for treating the identified condition.

The scope depends on the language used, particularly terms like "comprising," "consisting of," "for use," and "effective amount," which influence breadth.

Example (hypothetical):
"A pharmaceutical composition comprising a therapeutically effective amount of compound X and a carrier, wherein the composition is used to treat disease Y."

Claim Scope and Limitations

  • Broad Claims: Claims that encompass any formulation including compound X for disease Y, regardless of dosage, formulation, or delivery method. These provide strong market exclusivity but face a higher risk of prior art invalidation.
  • Narrow Claims: Focused on specific dosage forms, formulations, or treatment protocols. These are easier to defend but offer limited coverage.

Dependent Claims

Depend on the independent claim, adding specific features such as:

  • Particular doses.
  • Specific formulations (e.g., inhalation, injection, topical).
  • Additional components or excipients.
  • Details on stability or bioavailability.

Such claims provide fallback positions if broader claims are challenged.


Patent Landscape Analysis

Prior Art and Related Patents

The patent landscape surrounding DK1951684 involves examining prior art documents that disclose similar compositions, uses, or methods. This landscape includes:

  • Earlier patents on active compounds or classes of compounds similar to those claimed.
  • Existing formulations or therapeutic methods targeting the same disease or condition.
  • Patent filings from competitors seeking to secure rights in overlapping therapeutic areas.

Competitor and Inventor Portfolio

Understanding the patent holdings of key players, including companies and research institutions, identifies potential infringement risks or licensing opportunities. For example, if a competitor owns a patent on a similar compound or formulation, that patent could act as a barrier or cross-licensing opportunity.

Geographical Coverage

While DK1951684 is a Danish patent, its family might extend into:

  • European Patent Convention (EPC) regions via a family application.
  • International Patent Law (PCT) filings, affecting broader markets such as US, China, Japan, and other jurisdictions.

Coverage determines strategic IP protection and potential litigation risks.


Legal Status and Enforcement

Understanding whether DK1951684 is patentably strong involves assessing:

  • Maintenance status: Is it still in force, or has it lapsed?
  • Oppositions or legal challenges: Any history of legal disputes, which could influence enforcement.
  • Claims validity: Based on prior art submissions or patent examination reports.

Implications for Industry Stakeholders

  • Pharmaceutical Manufacturers: The broadness of claims influences R&D investment decisions, generic entry timing, and licensing strategies.
  • Patent Holders: The scope determines potential licensing revenue streams or litigation avenues.
  • Regulatory Bodies: Understanding patent scope informs market authorization and patent expiry timelines.

Conclusion

DK1951684 secures specific rights concerning a pharmaceutical composition or use, with its scope primarily defined by the language of its independent claims. Its positioning within the patent landscape hinges on the breadth of these claims versus existing prior art, with potential for overlapping rights in broader jurisdictions if patent family extensions exist.

Strategic considerations include analyzing potential infringement risks, licensing opportunities, and lifecycle management, leveraging the detailed claims and landscape positioning.


Key Takeaways

  • Claims Scope: The patent’s strength depends on the breadth of its independent claims. Broader claims confer wider exclusivity but face higher invalidation risks.
  • Patent Landscape: A comprehensive view requires mapping prior art and competitor portfolios, especially in overlapping therapeutic areas.
  • Jurisdictional Strategy: Extension of protections into major markets must consider patent family and regional differences.
  • Legal Status: Continuous monitoring of enforcement, opposition, and maintenance statuses is essential for strategic planning.
  • Innovation Positioning: This patent potentially fortifies a company's position in a competitive IP landscape, influencing licensing and litigation strategies.

FAQs

  1. What is the significance of the claims in DK1951684?
    The claims define the legal scope of the patent, establishing what is protected. Broader claims offer wider coverage but are more vulnerable to prior art challenges.

  2. Can DK1951684 be used to prevent competitors from entering the same market?
    Yes, if the claims are sufficiently broad and enforceable, the patent can restrict generic or competing products that infringe its scope within jurisdictions where it is granted and maintained.

  3. How does this patent relate to prior art?
    Its validity depends on novelty and inventive step compared to existing patents and publications. A thorough prior art search is critical for assessing enforceability.

  4. Does DK1951684 cover all formulations of the active compound?
    This depends on the claim language. If broad formulations are claimed, then multiple forms are covered; narrower claims limit protection to specific formulations.

  5. How might this patent landscape influence R&D decisions?
    Understanding the patent scope and threats enables companies to identify licensing opportunities, avoid infringement, or develop around protected claims.


References

[1] Danish Patent and Trademark Office (DKPTO). Patent DK1951684.
[2] European Patent Office (EPO). Patent family data.
[3] World Intellectual Property Organization (WIPO). Patent landscape reports.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.